Feng Lin
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Polyomavirus and related diseases
- Inflammatory Biomarkers in Disease Prognosis
-
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Diagnosis and Treatment 18
- Tracheal and airway disorders 8
- Sarcoma Diagnosis and Treatment 8
- Medical Imaging and Pathology Studies 4
- Pleural and Pulmonary Diseases 4
- Oncology 17
- Co-authors
- Chengwu Liu (24 shared papers)Lunxu Liu (23 shared papers)Qiang Pu (23 shared papers)Jiandong Mei (21 shared papers)Chenglin Guo (19 shared papers)Hu Liao (17 shared papers)Lin Ma (17 shared papers)Ram I. Mahato (2 shared papers)
- Journals
- QJM (4 papers)Annals of Translational Medicine (4 papers)Translational Lung Cancer Research (4 papers)European Journal of Cardio-Thoracic Surgery (2 papers)International Immunopharmacology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Feng Lin
73 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 103
- Oncology 265
- Pulmonary and Respiratory Medicine 282
- Immunology 175
- Rheumatology 60
- Cancer Research 59
Countries citing papers authored by Feng Lin
This map shows the geographic impact of Feng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Lin more than expected).
Fields of papers citing papers by Feng Lin
This network shows the impact of papers produced by Feng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Lin. The network helps show where Feng Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 153 | |
| 2 | 2017 | 109 | |
| 3 | 2018 | 64 | |
| 4 | 2008 | 52 | |
| 5 | 2008 | 50 | |
| 6 | 2019 | 48 | |
| 7 | 2020 | 42 | |
| 8 | 2007 | 37 | |
| 9 | 2015 | 35 | |
| 10 | 2009 | 34 | |
| 11 | 2014 | 29 | |
| 12 | 2016 | 28 | |
| 13 | 2013 | 26 | |
| 14 | 2022 | 26 | |
| 15 | 2014 | 25 | |
| 16 | 2016 | 21 | |
| 17 | 2017 | 15 | |
| 18 | 2020 | 14 | |
| 19 | 2017 | 12 | |
| 20 | 2017 | 12 |
About Feng Lin
Feng Lin is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 82 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (18 papers), Tracheal and airway disorders (8 papers), Sarcoma Diagnosis and Treatment (8 papers), Cardiac tumors and thrombi (5 papers), Medical Imaging and Pathology Studies (4 papers), Myasthenia Gravis and Thymoma (4 papers), Pleural and Pulmonary Diseases (4 papers) and Salivary Gland Tumors Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (265 citations), Pulmonary and Respiratory Medicine (282 citations), Immunology (175 citations), Rheumatology (60 citations) and Cancer Research (59 citations). Feng Lin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Chengwu Liu, Lunxu Liu, Qiang Pu, Jiandong Mei, Chenglin Guo, Hu Liao, Lin Ma, Ram I. Mahato, Zaixing Yang and Donghong Liu. Their work appears in journals such as QJM, Annals of Translational Medicine, Translational Lung Cancer Research, European Journal of Cardio-Thoracic Surgery and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.